Total synthesis and stereochemistry of mycolactone F

Journal of the American Chemical Society

Volumn 130, Issue 6, 2008, Pages 1842-1844

  Kim, Han Je ^a   Kishi, Yoshito ^a  

^a HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; MYCOLACTONE F; UNCLASSIFIED DRUG;

ARTICLE; BACTERIUM ISOLATE; CHEMICAL STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOMERISM; ISOMERIZATION; MYCOBACTERIUM MARINUM; MYCOBACTERIUM ULCERANS; PHOTOCHEMISTRY; PROTON NUCLEAR MAGNETIC RESONANCE; REACTION ANALYSIS; STEREOCHEMISTRY; STRUCTURE ANALYSIS; TOXIN SYNTHESIS;

FATTY ACIDS, UNSATURATED; LACTONES; MOLECULAR CONFORMATION; STEREOISOMERISM;

EID: 39049083577     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja7111838     Document Type: Article

References (34)

1. For a general review on Buruli ulcer, see: (a) Asiedu, K.; Scherpbier, R.; In Buruli ulcer: Mycobacterium ulcerans infection; Ravinglione, M., Ed.; World Health Organization: Geneva, Switzerland, 2000.
2. (b) Rohr, J.; Angew. Chem., Int. Ed. 2000, 39, 2847.
3. Marsollier, L.; Robert, R.; Aubry, J.; Saint Andre, J.-P.; Kouakou, H.; Legras, P.; Manceau, A.-L.; Mahaza, C.; Carbonnelle, B. Appl. Environ. Microbiol. 2002, 68, 4623.
4. George, K. M.; Chatterjee, D.; Gunawardana, G.; Welty, D.; Hayman, J.; Lee, R.; Small, P. L. C. Science 1999, 283, 854.
5. Gunawardana, G.; Chatterjee, D.; George, K. M.; Brennan, P.; Whittern, D.; Small, P. L. C. J. Am. Chem. Soc. 1999, 121, 6092.
6. (a) Benowitz, A. B.; Fidanze, S.; Small, P. L. C.; Kishi, Y. J. Am. Chem. Soc. 2001, 123, 5128.
7. (b) Fidanze, S.; Song, F.; Szlosek-Pinaud, M.; Small, P. L. C.; Kishi, Y. J. Am. Chem. Soc. 2001, 123, 10117.
8. (a) Song, F.; Fidanze, S.; Benowitz, A. B.; Kishi, Y. Org. Lett. 2002, 4, 647.
9. (b) Song, F.; Fidanze, S.; Benowitz, A. B.; Kishi, Y. Tetrahedron 2007, 63, 5739.
10. (a) Hong, H.; Gates, P. J.; Staunton, J.; Stinear, T.; Cole, S. T.; Leadlay, P. F.; Spencer, J. B. Chem. Commun. 2003, 2822.
11. (b) Mve-Obiang, A.; Lee, R. E.; Portaels, F.; Small, P. L. C. Infect. Immun. 2003, 71, 774.
12. Hong, H.; Spencer, J. B.; Porter, J. L.; Leadlay, P. F.; Stinear, T. ChemBioChem 2005, 6, 643.
13. Judd, T. C.; Bischoff, A.; Kishi, Y.; Adusumilli, S.; Small, P. L. C. Org. Lett. 2004, 6, 4901.
14. (a) Ranger, B. S.; Mahrous, E. A.; Mosi, L.; Adusumilli, S.; Lee, R. E.; Colorni, A.; Phodes, M.; Small, P. L. C. Infect. Immun. 2006, 74, 6037.
15. (b) Hong, H.; Stinear, T.; Porter, J.; Demangel, C.; Leadlay, P. F. ChemBioChem 2007, 8, 2043.
16. Gurjar, M. K.; Cherian, J. Heterocycles 2001, 55, 1095.
17. Tong, Z.; Ma, S.; Fuchs, P. L. J. Sulfur Chem. 2004, 25, 1.
18. van Summeren, R. P.; Feringa, B. L.; Minnaard, A. J. Org. Biomol. Chem. 2005, 3, 2524.
19. Yin, N.; Wang, G.; Qian, M.; Negishi, E. Angew. Chem., Int. Ed. 2006, 45, 2916.
20. Alexander, M. D.; Fontaine, S. D.; La Clair, J. J.; DiPasquale, A. G.; Rheingold, A. L.; Burkart, M. D. Chem. Commun. 2006, 4602.
21. Feyen, F.; Jantsch, A.; Altmann, K.-H. Synlett 2007, 415.
22. There was one additional minor isomer detected, which appeared to be (2′E4′Z,6′Z)-isomer.
23. See Supporting Information.
24. (a) Inanaga, J.; Hirata, K.; Saeki, H.; Katsuki, T.; Yamaguchi, M. Bull. Chem. Soc. Jpn. 1979, 52, 1989.
25. (b) Hikota, M.; Sakurai, Y.; Horita, K.; Yonemitsu, O. Tetrahedron Lett. 1990, 31, 6367.
26. The diagnostic chemical shifts suggest that this minor isomer corresponds to the fourth geometric isomer observed for 5: see ref 17.
27. Remote diastereomers are referred to as the diastereomers due to the stereocenter(s) present outside a self-contained box(es); see: (a) Kobayashi, K.; Tan, C.-H.; Kishi, Y. Helv. Chim. Acta 2000, 83, 2562.
28. (b) Boyle, C. D.; Harmange, J.-C.; Kishi, Y. J. Am. Chem. Soc. 1994, 116, 4995.
29. For the universal NMR database work, see: (a) Kobayashi, Y.; Lee, J.; Tezuka, K.; Kishi, Y. Org. Lett. 1999, 1, 2177.
30. (b) Seike, H.; Ghosh, I.; Kishi, Y. Org. Lett. 2006, 8, 3865 and references cited therein.
31. (a) Kobayashi, Y.; Hayashi, N.; Tan, C.-H. and Yoshito Kishi, Org. Lett. 2001, 3, 2245.
32. (b) Hayashi, N.; Kobayashi, Y.; Kishi, Y. Org. Lett. 2001, 3, 2249.
33. (c) Kobayashi, Y.; Hayashi, N.; Kishi, Y. Org. Lett. 2001, 3, 2253.
34. For the HPLC work, the crude lipid extract was directly used because only a very limited amount of natural mycolactone F was available. The total amount of material used for this study was approximately five times of one injection shown in Figure 2.